Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Controlled and Single-blind Study Assessing the Benefit/Risk Ratio of Internal Limiting Membrane (ILM) Peeling During Epimacular Membrane (EMM) Surgery

NCT02146144 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02146144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02146144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Controlled and Single-blind Study Assessing the Benefit/Risk Ratio of Internal Limiting Membrane (ILM) Peeling During Epimacular Membrane (EMM) Surgery
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 9, 2014
Completion date
March 14, 2022
Enrollment
213 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic epimacular membrane